536 related articles for article (PubMed ID: 21948561)
1. Beta2-agonists use during pregnancy and the risk of congenital malformations.
Eltonsy S; Forget A; Blais L
Birth Defects Res A Clin Mol Teratol; 2011 Nov; 91(11):937-47. PubMed ID: 21948561
[TBL] [Abstract][Full Text] [Related]
2. Risk of congenital malformations for asthmatic pregnant women using a long-acting β₂-agonist and inhaled corticosteroid combination versus higher-dose inhaled corticosteroid monotherapy.
Eltonsy S; Forget A; Beauchesne MF; Blais L
J Allergy Clin Immunol; 2015 Jan; 135(1):123-30. PubMed ID: 25226849
[TBL] [Abstract][Full Text] [Related]
3. Asthma exacerbations during the first trimester of pregnancy and the risk of congenital malformations among asthmatic women.
Blais L; Forget A
J Allergy Clin Immunol; 2008 Jun; 121(6):1379-84, 1384.e1. PubMed ID: 18410961
[TBL] [Abstract][Full Text] [Related]
4. Use of inhaled corticosteroids during the first trimester of pregnancy and the risk of congenital malformations among women with asthma.
Blais L; Beauchesne MF; Rey E; Malo JL; Forget A
Thorax; 2007 Apr; 62(4):320-8. PubMed ID: 17121872
[TBL] [Abstract][Full Text] [Related]
5. Effect of maternal asthma on the risk of specific congenital malformations: A population-based cohort study.
Blais L; Kettani FZ; Elftouh N; Forget A
Birth Defects Res A Clin Mol Teratol; 2010 Apr; 88(4):216-22. PubMed ID: 20099316
[TBL] [Abstract][Full Text] [Related]
6. Relative perinatal safety of salmeterol vs formoterol and fluticasone vs budesonide use during pregnancy.
Cossette B; Beauchesne MF; Forget A; Lemière C; Larivée P; Rey E; Blais L
Ann Allergy Asthma Immunol; 2014 May; 112(5):459-64. PubMed ID: 24656659
[TBL] [Abstract][Full Text] [Related]
7. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
8. Impact of maternal use of asthma-controller therapy on perinatal outcomes.
Cossette B; Forget A; Beauchesne MF; Rey É; Lemière C; Larivée P; Battista MC; Blais L
Thorax; 2013 Aug; 68(8):724-30. PubMed ID: 23585516
[TBL] [Abstract][Full Text] [Related]
9. Valproic acid monotherapy in pregnancy and major congenital malformations.
Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT;
N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369
[TBL] [Abstract][Full Text] [Related]
10. Maternal asthma, asthma medication use, and the risk of congenital heart defects.
Lin S; Herdt-Losavio M; Gensburg L; Marshall E; Druschel C
Birth Defects Res A Clin Mol Teratol; 2009 Feb; 85(2):161-8. PubMed ID: 19067406
[TBL] [Abstract][Full Text] [Related]
11. Risk of congenital anomalies after exposure to asthma medication in the first trimester of pregnancy - a cohort linkage study.
Garne E; Vinkel Hansen A; Morris J; Jordan S; Klungsøyr K; Engeland A; Tucker D; Thayer DS; Davies GI; Nybo Andersen AM; Dolk H
BJOG; 2016 Sep; 123(10):1609-18. PubMed ID: 27172856
[TBL] [Abstract][Full Text] [Related]
12. Beta2-agonists use during pregnancy and perinatal outcomes: a systematic review.
Eltonsy S; Kettani FZ; Blais L
Respir Med; 2014 Jan; 108(1):9-33. PubMed ID: 24360293
[TBL] [Abstract][Full Text] [Related]
13. Use of asthma medication during pregnancy and risk of specific congenital anomalies: A European case-malformed control study.
Garne E; Hansen AV; Morris J; Zaupper L; Addor MC; Barisic I; Gatt M; Lelong N; Klungsøyr K; O'Mahony M; Nelen V; Neville AJ; Pierini A; Tucker D; de Walle H; Wiesel A; Loane M; Dolk H
J Allergy Clin Immunol; 2015 Dec; 136(6):1496-1502.e7. PubMed ID: 26220526
[TBL] [Abstract][Full Text] [Related]
14. Asthma, asthma medications and their effects on maternal/fetal outcomes during pregnancy.
Rocklin RE
Reprod Toxicol; 2011 Sep; 32(2):189-97. PubMed ID: 21684328
[TBL] [Abstract][Full Text] [Related]
15. Asthma exacerbations during the first trimester of pregnancy and congenital malformations: revisiting the association in a large representative cohort.
Blais L; Kettani FZ; Forget A; Beauchesne MF; Lemière C
Thorax; 2015 Jul; 70(7):647-52. PubMed ID: 25888364
[TBL] [Abstract][Full Text] [Related]
16. Risk of perinatal mortality associated with inhaled corticosteroid use for the treatment of asthma during pregnancy.
Breton MC; Beauchesne MF; Lemière C; Rey É; Forget A; Blais L
J Allergy Clin Immunol; 2010 Oct; 126(4):772-777.e2. PubMed ID: 20920768
[TBL] [Abstract][Full Text] [Related]
17. Use of short-acting beta2-agonists during pregnancy and the risk of pregnancy-induced hypertension.
Martel MJ; Rey E; Beauchesne MF; Perreault S; Forget A; Maghni K; Lefebvre G; Blais L
J Allergy Clin Immunol; 2007 Mar; 119(3):576-82. PubMed ID: 17166573
[TBL] [Abstract][Full Text] [Related]
18. Major congenital malformations after first-trimester exposure to ACE inhibitors.
Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
[TBL] [Abstract][Full Text] [Related]
19. Quarterly assessment of short-acting beta(2)-adrenergic agonist use as a predictor of subsequent health care use for asthmatic patients in the United States.
Silver HS; Blanchette CM; Kamble S; Petersen H; Letter M; Meddis D; Gutierrez B
J Asthma; 2010 Aug; 47(6):660-6. PubMed ID: 20615167
[TBL] [Abstract][Full Text] [Related]
20. Triptan exposure during pregnancy and the risk of major congenital malformations and adverse pregnancy outcomes: results from the Norwegian Mother and Child Cohort Study.
Nezvalová-Henriksen K; Spigset O; Nordeng H
Headache; 2010 Apr; 50(4):563-75. PubMed ID: 20132339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
